Global Nebulizer Markets, 2023: Increasing Demand for Home Healthcare Devices - ResearchAndMarkets.com

September 6, 2018

DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Global Nebulizer Market - By Type and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The nebulizer market is expected to register a CAGR of about 6.5%, during the forecast period.Rising incidence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base are among the key factors driving market growth.

Increasing Demand for Home Healthcare Devices

The geriatric population is rising steadily. As aging is associated with the weakening of immune system, making an individual susceptible to diseases, the demand for home healthcare devices, such as nebulizers, inhalers, and glucose monitoring devices is expected to swell. Though all age groups use nebulizers for drug delivery for the treatment of respiratory diseases, people aged 60 and above prefer them the most due to the devices feasibility in home care.Since, many people shifted from hospital care to home care-based treatment, which has helped them take an active role in managing their diseases. They can opt for devices that allow better diagnosis and treatment of diseases from the comfort of their homes. These devices are easily available and are comfortable and easy to use. This shift led to the development of portable nebulizers. People use these devices for aerosol therapy at home, thus reducing the need for hospital stays. This trend will help in boosting the growth of the nebulizer market.Other factors that will affect the growth of the nebulizer market include; rising incidence of chronic respiratory diseases and rising geriatric population base.Other HighlightsDrug Loss during Drug DeliveryNorth America to Dominate the Market

Key Development in the Market

Tyvaso was approved by the FDA for the treatment of PAH in 2009, as a new drug-device combination product. This included Tyvaso plus an ultrasonic nebulizer and accessories - referred to as the Tyvaso Inhalation System.Companies FeaturedOmron CorporationKoninklijke Philips N.V.Pari PharmaAllied Healthcare Products Inc.Becton, Dickinson & CompanyAgilent TechnologiesMedline Industries Inc.Briggs HealthcareDrive MedicalGF Health Products Inc.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/l2pcfr/global_nebulizer?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005402/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Inhalers and Nebulisers,Respiratory Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 06:43 AM/DISC: 09/06/2018 06:43 AM


Update hourly